- To support: High-quality, hypothesis-driven diabetes research project
- Career level: A tenured research position
- Funding period: Up to five years
- Funding amount: Up to £500,000
- Deadline: 19 February 2025
- Funding decision: September 2025
Addressing health inequalities in diabetes
Research shows that diabetes does not affect everyone equally. Health inequalities have been widely reported in diabetes care for those from ethnic minority groups, for those who are socioeconomically disadvantaged, and for those with other protected characteristics.
Diabetes UK welcomes all applications for research which address the issue of inequality in diabetes.
We strongly encourage applications which are co-led by people with diabetes/community organisations/researchers from underserved groups.
Read the highlight notice (PDF, 262KB) and plain English summary (PDF, 103KB).
Applicants applying for £500,000 or more must contact Diabetes UK in the first instance and should already hold substantial funding from Diabetes UK or another funding body.
Please contact us at research@diabetes.org.uk to discuss further.
All applications will be sent out for external peer review.
Applicants will be given the opportunity to rebut peer reviewer comments. The anonymised peer reviews will be sent out via the Diabetes UK online grant management system, which allows applicants to submit their response (1,500-word limit). Applicant will be contacted for rebuttal in June/July.
Pre-selection process
Due to the high number of applications received by Diabetes UK, it is not possible to take forward all applications to the Research Committee for discussion. Therefore, following external peer review and rebuttal, applications undergo a pre-selection process, ratified by the Chair of the Research Committee and Committee members designated to speak to that application.
Applications that have not progressed through the pre-selection stage will be informed of the outcome before the Research Committee Meeting. Individual feedback is not provided for these applications.
Grants Advisory Panel and Research Committee
Prior to the Research Committee meeting, the Diabetes UK Grants Advisory Panel (GAP) will discuss all grant applications. GAP is comprised of people living with and affected by diabetes, who use the plain English summary of each grant application to establish how relevant the research is to people living with diabetes. Several GAP members attend the Research Committee to provide feedback.
The GAP perspective can directly influence the funding decision made. We recommend applicants take this into consideration, making sure the plain English summary section of your application is accessible and understandable to people from a non-scientific background.
Assessment criteria
Applications are assessed on the following criteria:
Funding decision
Feedback letters will be sent to all lead applicants within one month of the Research Committee meeting.
Funded applicants will have two weeks to respond to comments raised by the Committee.
Funded applicants should expect to receive an award letter within two months of the Research Committee meeting.
Resubmissions
Diabetes UK policy is to only accept resubmissions which have been invited by the Research Committee. You will be informed in your feedback letter if you have been invited for a resubmission. When resubmitting an application, please include a cover letter indicating how the application has addressed the Research Committee's comments.
If your project grant is in the area of the Type 1 Diabetes Grand Challenge focused replacing and regenerating beta cells, we ask that you contact Research@diabetes.org.uk to discuss your application in the first instance.
Eligible Countries:
Sponsor Institute/Organizations: Diabetes UK
Sponsor Type:
Address: Wells Lawrence House 126 Back Church Lane London E1 1FH
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Feb 19, 2025
Feb 19, 2025
$519,612
£500,000
Affiliation: Diabetes UK
Address: Wells Lawrence House 126 Back Church Lane London E1 1FH
Website URL: https://www.diabetes.org.uk/our-research/for-researchers/applying-for-funding/funding-schemes/project-grants
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.